Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Anne Pizard"'
Autor:
Emmanuel Bresso, João Pedro Ferreira, Arantxa González, Jean-Loup Machu, Céline Leroy, Stephane Heymans, Hans-Peter Brunner-La-Rocca, Marie-Dominique Devignes, Nicolas Girerd, Faiez Zannad, Javier Díez, Patrick Rossignol, Anne Pizard
Publikováno v:
Clinical Research in Cardiology
Clinical Research in Cardiology, Springer Verlag, 2020, 109, pp.22-33. ⟨10.1007/s00392-019-01480-4⟩
Clinical Research in Cardiology, Springer Verlag, 2020, 109 (1), pp.22-33. ⟨10.1007/s00392-019-01480-4⟩
Clinical Research in Cardiology, 2020, 109 (1), pp.22-33. ⟨10.1007/s00392-019-01480-4⟩
Clinical research in cardiology, 109(1), 22-33. Springer
Clinical Research in Cardiology, Springer Verlag, 2020, 109, pp.22-33. ⟨10.1007/s00392-019-01480-4⟩
Clinical Research in Cardiology, Springer Verlag, 2020, 109 (1), pp.22-33. ⟨10.1007/s00392-019-01480-4⟩
Clinical Research in Cardiology, 2020, 109 (1), pp.22-33. ⟨10.1007/s00392-019-01480-4⟩
Clinical research in cardiology, 109(1), 22-33. Springer
Background Hypertension, obesity and diabetes are major and potentially modifiable "risk factors" for cardiovascular diseases. Identification of biomarkers specific to these risk factors may help understanding the underlying pathophysiological pathwa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::83f0b29ae639a0a986aa07ebff2fca3b
https://hal.inria.fr/hal-02138814
https://hal.inria.fr/hal-02138814
Publikováno v:
European Journal of Heart Failure. 19:974-986
The aim of personalized medicine is to offer a tailored approach to each patient in order to provide the most effective therapy, while reducing risks and side effects. The use of mineralocorticoid receptor antagonists (MRAs) has demonstrated major be
Autor:
Jean Loup Machu, Timothy Collier, Stuart J. Pocock, Nicolas Girerd, Arnaud Olivier, Bertram Pitt, Patrick Rossignol, Dirk J. van Veldhuisen, Karl Swedberg, Zohra Lamiral, Anne Pizard, John J.V. McMurray, Faiez Zannad
Publikováno v:
European Journal of Heart Failure. 19:1186-1197
Aims An excessive production of aldosterone influences outcome in patients with heart failure (HF) and in obese patients. Findings from laboratory studies suggest that chronic aldosterone blockade maybe more beneficial in abdominally obese HF-prone r
Autor:
Isbaal Ramos, Hüseyin Firat, Javier Díez, Quoc-Tuan Do, Mariann Gyöngyösi, Frederic Jaisser, Johannes Winkler, Arantxa González, Kenneth McDonald, Faiez Zannad, Anne Pizard, Thomas Thum
Publikováno v:
European Journal of Heart Failure
Myocardial fibrosis refers to a variety of quantitative and qualitative changes in the interstitial myocardial collagen network that occur in response to cardiac ischaemic insults, systemic diseases, drugs, or any other harmful stimulus affecting the
Autor:
Lotte Jacobs, Ljupcho Efremov, João Pedro Ferreira, Lutgarde Thijs, Wen‐Yi Yang, Zhen‐Yu Zhang, Roberto Latini, Serge Masson, Nera Agabiti, Peter Sever, Christian Delles, Naveed Sattar, Javed Butler, John G. F. Cleland, Tatiana Kuznetsova, Jan A. Staessen, Faiez Zannad, Florence Pinet, Anne Pizard, Philippe Rouet, Joost Leenders, Javier Diez, Augustine Odili, Fang‐Fei Wei, Anne Newman, Lampros Papadimitrious, Marina Davoli, Gian Francesco Mureddu, Ian Ford, Wouter Jukema, David J. Stott, Neil Poulter
Publikováno v:
Journal of the American Heart Association
Journal of the American Heart Association, Wiley-Blackwell, 2017, 6 (5), pp.e005231. ⟨10.1161/JAHA.116.005231⟩
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Journal of the American Heart Association, Wiley-Blackwell, 2017, 6 (5), pp.e005231. ⟨10.1161/JAHA.116.005231⟩
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Background To address the need for personalized prevention, we conducted a subject‐level meta‐analysis within the framework of the Heart “OMics” in AGEing (HOMAGE) study to develop a risk prediction model for heart failure (HF) based on routi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3cb3498b2a6cba5f4dddb75eafed334d
https://hal.archives-ouvertes.fr/hal-02267421
https://hal.archives-ouvertes.fr/hal-02267421
Preventive and chronic mineralocorticoid receptor antagonism is highly beneficial in obese SHHF rats
Autor:
Carlos Labat, Muller A, Faiez Zannad, Rosa-Maria Rodriguez-Guéant, Patrick Lacolley, Nicot N, Renaud Fay, Frederic Jaisser, Deng C, Arnaud Olivier, Leroy C, Gina Youcef, Anne Pizard, Laurent Vallar
Publikováno v:
British Journal of Pharmacology. 173:1805-1819
Background and purpose Mineralocorticoid receptor (MR) activation contributes to heart failure (HF) progression. Its overactivity in obesity is thought to accelerate cardiac remodelling and HF development. Given that MR antagonists (MRA) are benefici
Autor:
Chaohua Deng, Cécile Guillaume, Meriem Koufany, Anne Pizard, Arnaud Bianchi, Hervé Kempf, Nathalie Presle, David Moulin
Publikováno v:
Annals of the Rheumatic Diseases
Annals of the Rheumatic Diseases, BMJ Publishing Group, 2018, 77 (5), pp.e26-e26. ⟨10.1136/annrheumdis-2017-212003⟩
Annals of the Rheumatic Diseases, 2018, 77 (5), pp.e26-e26. ⟨10.1136/annrheumdis-2017-212003⟩
Annals of the Rheumatic Diseases, BMJ Publishing Group, 2018, 77 (5), pp.e26-e26. ⟨10.1136/annrheumdis-2017-212003⟩
Annals of the Rheumatic Diseases, 2018, 77 (5), pp.e26-e26. ⟨10.1136/annrheumdis-2017-212003⟩
We thank Dr Chan and Dr Wen for their interest in our report1 and their resulting eLetter.2 We fully agree that, among the different components of metabolic syndrome (MetS), hypertension has very recently been brought out as a critical feature in the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8416ddf54b2c87b29a94076b8a5da12d
https://hal.univ-lorraine.fr/hal-02983106
https://hal.univ-lorraine.fr/hal-02983106
Autor:
Jean-Loup Machu, João Pedro Ferreira, Anne-Cecile Huby, Timothy Collier, Naveed Sattar, Javier Díez, Peter S. Sever, Nicolas Girerd, John G.F. Cleland, Faiez Zannad, Anne Pizard, Arantxa González, Patrick Rossignol, Begoña López
Publikováno v:
Heart (British Cardiac Society). 105(4)
BackgroundAn increase in myocardial collagen content may contribute to the development of heart failure; this might be inhibited or reversed by mineralocorticoid receptor antagonists (MRAs). We investigated changes in serum concentrations of the coll
Autor:
Anne Pizard, Hervé Kempf, Chaohua Deng, Arnaud Bianchi, Meriem Koufany, David Moulin, Cécile Guillaume, Nathalie Presle
Publikováno v:
Annals of the Rheumatic Diseases
Annals of the Rheumatic Diseases, BMJ Publishing Group, 2018, 77 (2), pp.315-316. ⟨10.1136/annrheumdis-2016-210700⟩
Annals of the Rheumatic Diseases, 2018, 77 (2), pp.315-316. ⟨10.1136/annrheumdis-2016-210700⟩
Annals of the Rheumatic Diseases, BMJ Publishing Group, 2018, 77 (2), pp.315-316. ⟨10.1136/annrheumdis-2016-210700⟩
Annals of the Rheumatic Diseases, 2018, 77 (2), pp.315-316. ⟨10.1136/annrheumdis-2016-210700⟩
Increasing epidemiological and clinical studies suggest that metabolic syndrome (MetS) plays a role in the incidence and progression of osteoarthritis (OA).1 2 However, in absence of an appropriate MetS-associated OA experimental model,3 the MetS con
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::02e2e33e81d407bd886dddac08831d2a
https://hal.univ-lorraine.fr/hal-01702028
https://hal.univ-lorraine.fr/hal-01702028
Autor:
Thomas Thum, Faiez Zannad, Anne Pizard, Natalia López-Andrés, Anna-Pia Papageorgiou, Arantxa González, Stephane Heymans, Javier Díez, Frederic Jaisser
Publikováno v:
European Journal of Heart Failure. 17:764-771
Myocardial fibrosis is the result of excessive fibrillar collagen synthesis and deposition without reciprocally balanced degradation. It causes cardiac dysfunction, arrhythmias, and ischaemia, and thereby determines the clinical course and outcome of